SCHIEPATTI, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 3.436
AS - Asia 1.882
EU - Europa 1.599
SA - Sud America 269
Continente sconosciuto - Info sul continente non disponibili 176
AF - Africa 78
OC - Oceania 9
Totale 7.449
Nazione #
US - Stati Uniti d'America 3.280
CN - Cina 643
SG - Singapore 506
IT - Italia 440
IE - Irlanda 273
RU - Federazione Russa 242
VN - Vietnam 215
HK - Hong Kong 199
BR - Brasile 178
DE - Germania 172
FR - Francia 101
FI - Finlandia 92
GB - Regno Unito 92
CA - Canada 79
IN - India 77
BD - Bangladesh 75
AR - Argentina 33
ZA - Sudafrica 29
JP - Giappone 28
PT - Portogallo 25
TR - Turchia 22
EC - Ecuador 21
NL - Olanda 21
ES - Italia 19
IL - Israele 19
PL - Polonia 19
SE - Svezia 19
SC - Seychelles 18
IQ - Iraq 16
BE - Belgio 14
MX - Messico 14
LT - Lituania 13
AT - Austria 12
CO - Colombia 12
CR - Costa Rica 12
MA - Marocco 12
UA - Ucraina 11
GT - Guatemala 10
PH - Filippine 10
VE - Venezuela 10
SA - Arabia Saudita 9
AU - Australia 8
EG - Egitto 8
ID - Indonesia 8
PK - Pakistan 8
TT - Trinidad e Tobago 8
BO - Bolivia 6
HN - Honduras 6
JM - Giamaica 6
KR - Corea 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
CW - ???statistics.table.value.countryCode.CW??? 5
HU - Ungheria 5
JO - Giordania 5
MY - Malesia 5
NI - Nicaragua 5
NP - Nepal 5
PR - Porto Rico 5
CH - Svizzera 4
GR - Grecia 4
CL - Cile 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GP - Guadalupe 3
HR - Croazia 3
IR - Iran 3
MD - Moldavia 3
SV - El Salvador 3
UY - Uruguay 3
CY - Cipro 2
LB - Libano 2
LU - Lussemburgo 2
PY - Paraguay 2
RO - Romania 2
SN - Senegal 2
TN - Tunisia 2
AD - Andorra 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
DZ - Algeria 1
GE - Georgia 1
GY - Guiana 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LV - Lettonia 1
ML - Mali 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
QA - Qatar 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 7.276
Città #
Dallas 390
San Jose 338
Ashburn 312
Dublin 273
Singapore 265
Council Bluffs 219
Hong Kong 197
Beijing 173
Chandler 141
New York 104
Los Angeles 102
Munich 74
Ho Chi Minh City 68
Lauterbourg 66
Milan 66
Boardman 62
Hanoi 52
Helsinki 51
Nanjing 50
Santa Clara 45
Shanghai 44
Moscow 41
Rome 38
Orem 37
Buffalo 35
Naples 29
Ann Arbor 27
Redondo Beach 27
São Paulo 27
Turku 27
Tokyo 26
Lawrence 25
Montreal 25
Pavia 25
Princeton 25
Columbus 24
Jacksonville 24
Johannesburg 23
Medford 22
Shenyang 22
Atlanta 21
Brooklyn 20
Chennai 20
Phoenix 20
San Francisco 20
Changsha 19
Frankfurt am Main 19
London 19
Wilmington 18
Chicago 17
Hebei 17
Nanchang 17
Da Nang 15
Denver 15
Linda a Velha 15
Tampa 15
Toronto 15
Turin 15
Warsaw 15
Nuremberg 14
Boston 13
Brussels 13
Hangzhou 12
Jiaxing 12
Poplar 12
Seattle 12
The Dalles 12
West Jordan 12
Figino 11
Amsterdam 10
Manchester 10
Pune 10
Stockholm 10
San José 9
Tianjin 9
Biên Hòa 8
Bologna 8
Casablanca 8
Falls Church 8
Brasília 7
Buenos Aires 7
Cagliari 7
Guatemala City 7
Guayaquil 7
Houston 7
Monza 7
Newark 7
North Bergen 7
Quito 7
Rio de Janeiro 7
Washington 7
Charlotte 6
Düsseldorf 6
Falkenstein 6
Haiphong 6
Hyderabad 6
Medellín 6
Mexico City 6
Norwalk 6
Philadelphia 6
Totale 4.304
Nome #
Remineralizing Treatments for Dental Erosion and Sensitivity in Patients Suffering from Gastroesophageal Reflux Disease (GERD): Randomized Clinical Trial 309
Study of the microbiota composition in adult celiac disease 227
STUDY OF THE CLINICAL AND MOLECULAR PHENOTYPE AND NATURAL HISTORY OF ENTEROPATHIES WITH VILLOUS ATROPHY OF UNKNOWN ORIGIN AND THERAPEUTIC POTENTIAL OF BONE MARROW DERIVED MESENCHYMAL STEM CELLS 187
Long-term morbidity and mortality in Whipple's disease: A single-center experience over 20 years 185
Distinguishing Features of Autoimmune Gastritis Depending on Previous Helicobacter pylori Infection or Positivity to Anti-Parietal Cell Antibodies: Results From the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO) 184
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium 174
A multicentre case control study on complicated coeliac disease: two different patterns of natural history, two different prognoses. 169
Humoral immunogenicity of COVID-19 vaccines in patients with coeliac disease and other noncoeliac enteropathies compared to healthy controls 141
Clinical and laboratory predictors and prevalence of immune reconstitution inflammatory syndrome in patients with Whipple's disease 140
Comparative Study of Salivary, Duodenal, and Fecal Microbiota Composition Across Adult Celiac Disease 138
New entity of adult ultra-short coeliac disease: the first international cohort and case–control study 137
Systematic review: Clinical phenotypes, histopathological features and prognosis of enteropathy due to angiotensin II receptor blockers 135
Systematic review with meta-analysis: Cause-specific and all-cause mortality trends across different coeliac disease phenotypes 123
Study of the microbiota composition in adult celiac disease 117
Flow cytometry for the assessment and monitoring of aberrant intraepithelial lymphocytes in non-responsive celiac disease and non-celiac enteropathies 114
High Prevalence of Functional Gastrointestinal Disorders in Celiac Patients with Persistent Symptoms on a Gluten-Free Diet: A 20-Year Follow-Up Study 114
A second duodenal biopsy is necessary in the follow-up of adult coeliac patients. 113
−295 T-to-C promoter region IL-16 gene polymorphism is associated with Whipple’s disease 111
Is a detailed grading of villous atrophy necessary for the diagnosis of enteropathy? 110
Olmesartan-associated enteropathy: New insights on the natural history? Report of two cases 110
Musculoskeletal Ultrasound to Identify Subclinical Joint and Periarticular Involvement in Patients With Inflammatory Bowel Disease: A Systematic Literature Review 110
Pitfalls in the diagnosis of coeliac disease and gluten-related disorders 108
Clinical and gastro-duodenal histopathological features of enteropathy due to angiotensin II receptor blockers 107
Low prevalence of upper endoscopic gastrointestinal findings despite high frequency of alarm symptoms at the time of diagnosis in adult coeliac disease 106
Fecal calprotectin measurement as a biomarker of severe disease phenotype in celiac disease and non-celiac enteropathies 105
Coeliac disease and obstetric and gynaecological disorders: Where are we now? 104
Comparison between SeHCAT test and clinical response to cholestyramine in patients with chronic diarrhea and high suspicion of bile acid malabsorption: A single-center prospective study 104
The GLU-10: a validated ten-point score to identify poorly instructed celiac patients in need of dietary interventions 103
Clinical classification and long-term outcomes of seronegative coeliac disease: a 20-year multicentre follow-up study 102
The Relationship Between Child Mortality Rates and Prevalence of Celiac Disease 101
Clinical phenotype and mortality in patients with idiopathic small bowel villous atrophy: a dual-centre international study 101
Optimising the follow-up of adult coeliac disease with a clinical-based score to identify patients in need of a histological reassessment: A retrospective single centre study 101
Short article: Mortality and differential diagnoses of villous atrophy without coeliac antibodies 98
DQA1*0102 DQB1*0602 haplotype distinguishes coeliac disease and its complications from gluten unrelated enteropathies 98
Prevalence, incidence and clinical features of SARS-CoV-2 infection in adult coeliac patients 97
Superior bowel preparation quality for colonoscopy with 1L-PEG compared to 2L-PEG and picosulphate: Data from a large real-world retrospective outpatient cohort 96
Efficacy of a Low-FODMAP Diet for Coeliac Patients with Persistent IBS-like Symptoms despite a Gluten-Free Diet: A Systematic Review 96
Seronegative coeliac disease: clearing the diagnostic dilemma 92
Determinants and Trends of Adherence to a Gluten-Free Diet in Adult Celiac Patients on a Long-term Follow-up (2000–2020) 88
Inadvertent and minimal gluten intake has a negligible role in the onset of symptoms in patients with coeliac disease on a gluten-free diet 87
Relationship between duodenal microbiota composition, clinical features at diagnosis, and persistent symptoms in adult Coeliac disease 86
Is it time to rethink the burden of non-coeliac gluten sensitivity? A systematic review 85
A small bowel adenocarcinoma harboring a DDR2 mutation in a celiac patient 85
Nomenclature and diagnosis of seronegative coeliac disease and chronic non-coeliac enteropathies in adults: the Paris consensus 82
Prevalence of Whipple's disease in north-western Italy 82
Overview in the clinical management of patients with seronegative villous atrophy 79
The high mortality of patients with common variable immunodeficiency and small bowel villous atrophy 77
Clinical outcomes of potential coeliac disease: a systematic review and meta-analysis 76
Persistent villous atrophy predicts development of complications and mortality in adult patients with coeliac disease: a multicentre longitudinal cohort study and development of a score to identify high-risk patients 73
Enteropathies with villous atrophy but negative coeliac serology in adults: Current issues 69
Patients with Whipple's disease have a high prevalence of Helicobacter pylori infection 68
Prognosticating coeliac patients survival: the proconsul score. 65
Prevalence and clinical features of bile acid diarrhea in patients with chronic diarrhea 65
Long-Term Adherence to a Gluten-Free Diet and Quality of Life of Celiac Patients After Transition to an Adult Referral Center 64
Applications of generative artificial intelligence in inflammatory bowel disease: A systematic review 64
Biopsy‐Sparing Diagnosis of Coeliac Disease Based on Endomysial Antibody Testing and Clinical Risk Assessment 62
Risk of complications in coeliac patients depends on age at diagnosis and type of clinical presentation 60
A multicenter study on bowel preparation in inflammatory bowel disease patients: comparison between 1L-PEG-ASC and 2L-PEG regimens in an outpatient setting 59
Small bowel villous atrophy due to immune-checkpoint inhibitors: report of two cases and literature review 58
Work Impairment in Patients with Celiac Disease and Its Relationship with Persistence of Symptoms, Dietary Adherence, Quality of Life, and Psychological Morbidity 53
Seronegative villous atrophy 51
The high prevalence of Whipple's disease in patients with inflammatory rheumatic diseases 50
Author's Reply: “Comment on gluten challenge study in adults on a gluten-free diet with unconfirmed coeliac disease” 49
HLA-DQ7.5 and coeliac disease 48
Resilience in Adult Coeliac Patients on a Gluten-Free Diet: A Cross-Sectional Multicentre Italian Study 47
Global prevalence of celiac disease in patients with Rome III and Rome IV irritable bowel syndrome: A systematic review and meta-analysis 46
Prevalence of gastroesophageal reflux disease in adult coeliac disease at diagnosis and during follow-up: a 20-year retrospective study 46
Beyond gluten-free diet: a critical perspective on phase 2 trials on non-dietary pharmacological therapies for coeliac disease 45
LONG-TERM PROGNOSIS of NON-CELIAC ENTEROPATHIES and A SCORE to IDENTIFY PATIENTS with POOR OUTCOMES: A 30-YEAR MULTICENTER LONGITUDINAL STUDY 44
Use of small-bowel capsule endoscopy in cases of equivocal celiac disease 44
Diagnostic outcomes after gluten challenge in adult patients with unconfirmed coeliac disease already on a gluten‐free diet: A 20‐year retrospective cohort study 43
Letter: The enigma of angiotensin receptor blocker-associated enteropathy—Authors' reply 43
Nonresponsive and complicated coeliac disease 42
Non-Coeliac Wheat Sensitivity: Symptoms in Search of a Mechanism, or a Distinct Well-Defined Clinical Entity? A Narrative Review 40
Endoscopic techniques for the identification of duodenal villous atrophy in celiac disease: a systematic review and meta-analysis of diagnostic accuracy 40
Seronegative coeliac disease masquerading as irritable bowel syndrome type symptoms 39
Is it time to abandon night-before laxative bowel preparation for small-bowel capsule endoscopy? 34
Reply 33
Editorial: Endomysial Antibodies for a No-Biopsy Diagnosis of Coeliac Disease—The Jury Is Still out. Authors' Reply 33
Development and pilot evaluation of a large language model-based clinical simulation system for medical education in gastroenterology 31
European Society for the Study of Coeliac Disease 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 1: Diagnostic Approach 31
Prevalence and incidence of celiac disease in patients with rheumatoid arthritis: a case-control study based on the RECORD cohort 23
Diagnostic yield and usefulness of terminal ileal intubation in asymptomatic patients undergoing colonoscopy for colorectal cancer screening or postpolypectomy surveillance: a systematic review and meta-analysis 23
null 20
Risk Factors for Inadequate Bowel Preparation Before Colonoscopy in Patients with Ulcerative Colitis in Clinical and Endoscopic Remission: A Multicenter Retrospective Cohort Study 18
Commentary: Prevalence and incidence of celiac disease in patients with rheumatoid arthritis: a case-control study based on the RECORD cohort 14
European Society for the Study of Coeliac Disease (ESsCD) 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 2: Management, Follow-Up, and Complex Disease Courses 9
Diagnosis, management and long-term outcomes of seronegative enteropathies in adults: a practical review 9
Totale 7.449
Categoria #
all - tutte 31.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.741


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022121 0 0 0 0 6 11 4 13 7 8 14 58
2022/2023653 61 42 0 25 28 67 54 33 305 7 13 18
2023/2024490 52 67 9 24 21 99 33 15 2 100 33 35
2024/20251.150 49 79 30 28 21 110 52 57 277 47 148 252
2025/20263.214 207 179 427 403 385 102 457 157 365 204 201 127
2026/20271.502 190 225 301 513 273 0 0 0 0 0 0 0
Totale 7.449